Related Articles
Clinical presentation of anaplastic large‑cell lymphoma in the central nervous system
Breast implant‑associated anaplastic large‑cell lymphoma and the role of brentuximab vedotin (SGN‑35) therapy: A case report and review of the literature
A combination of PD‑1/PD‑L1 inhibitors: The prospect of overcoming the weakness of tumor immunotherapy (Review)
Immune checkpoint inhibitors in metastatic melanoma therapy (Review)
Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma